What the FDA’s rule changes allowing the abortion pill mifepristone to be dispensed by pharmacies mean in practice – 5 questions answered Read more
PRAPELA RECEIVES FDA’S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY Read more
FDA’s Push To Reclassify The Opioid Reversal Agent Naloxone As An OTC Product Needs To Show More Urgency Read more
The FDA’s New Proposed Definition of “Healthy” Is an Advance, but Pretending the Term Can Ever Be Clearly Defined Isn’t Read more